Conclusion:
This study shows the potential of cell-based, genome-wide approaches to identify germline predictors of treatment outcome
and highlights the need for extensive validation in patients to assess their clinical effect.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.